Log in to save to my catalogue

Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics appro...

Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics appro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8e897a0c9b45412993f888401393b048

Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach

About this item

Full title

Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach

Publisher

United States: John Wiley & Sons, Inc

Journal title

Molecular oncology, 2022-07, Vol.16 (14), p.2658-2671

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Neoadjuvant chemotherapy (NACT) outcomes vary according to breast cancer (BC) subtype. Since pathologic complete response is one of the most important target endpoints of NACT, further investigation of NACT outcomes in BC is crucial. Thus, identifying sensitive and specific predictors of treatment response for each phenotype would enable early dete...

Alternative Titles

Full title

Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8e897a0c9b45412993f888401393b048

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8e897a0c9b45412993f888401393b048

Other Identifiers

ISSN

1574-7891,1878-0261

E-ISSN

1878-0261

DOI

10.1002/1878-0261.13216

How to access this item